Literature DB >> 10734521

Antibody levels to Salmonella typhi and paratyphi in Nigerians.

K B Tanyigna1, J A Ayeni, E N Okeke, J A Onah, C S Bello.   

Abstract

OBJECTIVE: To determine the antibody titre levels to typhoid/paratyphoid fever organisms among apparently healthy volunteers.
DESIGN: Cross sectional study.
SETTING: General community and University Teaching Hospital. PARTICIPANTS: Volunteer sample of 323 apparently healthy individuals with body temperatures < or = 37.8 degrees C. MAIN OUTCOME MEASURES: Questionnaire administration to classify volunteers into three socio-economic status (SES).
RESULTS: There were 35.29% of the apparently healthy population in Jos community with antibodies to typhoid/paratyphoid fever organisms. The presence of these antibodies were neither sex nor SES related. Normal antibody titres were up to 1:40 and 1:80 for O and H Salmonella antigens respectively. Contrary to the general belief, typhoid/paratyphoid fevers have not affected virtually everybody in Nigeria. The difference between those without previous history and those with previous history was significant (p < 0.05) with those in the former category having a higher percentage.
CONCLUSION: For a single sero-diagnosis to have any diagnostic value in Jos community and its environs, only a four-fold rise to what has been found to be normal should be significant. This means that only titres of 1:160 and 1:320 and above for O and H antigens should be considered significant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10734521

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  1 in total

1.  Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal.

Authors:  Anoop S Pulickal; Samir Gautam; Elizabeth A Clutterbuck; Stephen Thorson; Buddha Basynat; Neelam Adhikari; Katherine Makepeace; Sjoerd Rijpkema; Ray Borrow; Jeremy J Farrar; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2009-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.